ingenol mebutate gel 0.05%

DRUG2 trials

Sponsors

LEO Pharma, Korea University

Conditions

Actinic Keratosis

Phase 1

Histological Confirmation of Clinical Clearance of Actinic Keratoses Following Treatment With Ingenol Mebutate Gel, 0.05%

CompletedNCT01892137

LEO PharmaActinic Keratosis

Start: 2013-07-31End: 2014-05-31Updated: 2025-02-24

Phase 4

Clinical Trial of Ingenol Mebutate Gel 0.015% & 0.05% in Actinic Keratosis

CompletedNCT02716714

Korea UniversityActinic Keratosis

Start: 2015-04-30End: 2016-06-30Updated: 2018-04-18

Related Papers

A multicentre, open, investigator-initiated phase IV clinical trial to evaluate the efficacy and safety of ingenol mebutate gel, 0·015% on the face and scalp, and 0·05% on the trunk and extremities, in Korean patients with actinic keratosis (PERFECT).

2018-05-145 citations